tiprankstipranks
Trending News
More News >
United-guardian (UG)
:UG
US Market
Advertisement

United-Guardian (UG) Price & Analysis

Compare
158 Followers

UG Stock Chart & Stats


United-Guardian News

UG FAQ

What was United-guardian’s price range in the past 12 months?
United-guardian lowest stock price was $7.73 and its highest was $16.25 in the past 12 months.
    What is United-guardian’s market cap?
    United-guardian’s market cap is $36.80M.
      When is United-guardian’s upcoming earnings report date?
      United-guardian’s upcoming earnings report date is Aug 08, 2025 which is in 5 days.
        How were United-guardian’s earnings last quarter?
        Currently, no data Available
        Is United-guardian overvalued?
        According to Wall Street analysts United-guardian’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does United-guardian pay dividends?
          United-guardian pays a Semiannually dividend of $0.25 which represents an annual dividend yield of 7.49%. See more information on United-guardian dividends here
            What is United-guardian’s EPS estimate?
            United-guardian’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does United-guardian have?
            United-guardian has 4,594,319 shares outstanding.
              What happened to United-guardian’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of United-guardian?
              Currently, no hedge funds are holding shares in UG

              Company Description

              United-guardian

              United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

              United-Guardian (UG) Earnings & Revenues

              Currently, no data available
              Please return soon. This page is being updated.
              Similar Stocks
              Company
              Price & Change
              Follow
              Crown Crafts
              Regis
              Sypris
              Natural Health Trends

              Ownership Overview

              7.28%9.74%79.41%
              Insiders
              9.74% Other Institutional Investors
              79.41% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis